OTC:APYP
APPYEA, INC
A distressed micro-cap stock with negligible revenue, massive negative net income, and a balance sheet dominated by liabilities and accumulated deficits.
Key Metrics
Investment Thesis
Bull Case
An aggressive investor might view APYP as a turnaround candidate if the company can pivot its business model away from dilution-heavy financing. The low market cap and availability of insider share issuances could offer high percentage gains if the company successfully launches a viable product or secures major contracts.
Bear Case
Avoid this stock entirely as it exhibits classic signs of a value trap with no path to profitability in sight. The widening losses, negative equity position, and lack of revenue growth make it an unsuitable investment for risk-averse capital seeking preservation.
About APPYEA, INC
APPYEA, INC (APYP) is a micro-cap entity operating with minimal revenue of $29k and significant accumulated deficits. The company reports substantial non-cash adjustments including share issuances and depreciation, suggesting potential restructuring or development phase activities rather than standard commercial operations. Financial statements indicate heavy reliance on financing cash flows to offset severe operating losses.
Analysis
Management Discussion
Recent financial performance deteriorates significantly, with net income widening to a loss of $4.0M in 2024 compared to prior years. Cash burn is unsustainable at -$785k from operations, requiring reliance on equity financing which has increased paid-in capital but failed to generate profitable operations.
Industry Overview
The company operates in a highly volatile micro-cap sector where survival depends on continuous fundraising rather than operational cash flow. Many peers in this space struggle to transition from burn-heavy development phases to commercial viability without external support.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $29.0K |
| Cost of Revenue | $0 | $0 | $15.0K |
| Gross Profit | $0 | $0 | $14.0K |
| Operating Expenses | $2.2M | $1.6M | $1.8M |
| Operating Income | $-2.2M | $-1.6M | $-1.8M |
| R&D | $129.0K | $124.0K | $339.0K |
| G&A | $2.0M | $1.4M | $1.1M |
| Marketing | $16.0K | $128.0K | $385.0K |
| Stock-Based Comp | $1.1M | $796.0K | $1.0M |
| D&A | $24.0K | $25.0K | $24.0K |
| Depreciation | $200 | — | — |
| Other OpEx | $0 | $0 | $0 |
| Non-Operating Income | $0 | $-179.0K | $-2.2M |
| Pre-Tax Income | $-2.2M | $-1.8M | $-4.0M |
| Income Tax | $-858.0K | $0 | $0 |
| Continuing Ops | $-1.3M | $-1.8M | $-4.0M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-1.3M | $-1.8M | $-4.0M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-1.3M | $-1.8M | $-4.0M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $79.0K | $278.0K | $131.0K |
| Cash & Equivalents | $60.0K | $222.0K | $79.0K |
| Inventory | — | $14.0K | $23.0K |
| Other Current Assets | $19.0K | $42.0K | $29.0K |
| Long-Term Assets | $126.0K | $196.0K | $254.0K |
| PP&E (Net) | $2.0K | $3.0K | $3.0K |
| Intangibles | — | — | $251.0K |
| Other LT Assets | $124.0K | $193.0K | $0 |
| Total Assets | $205.0K | $474.0K | $385.0K |
| Current Liabilities | $2.8M | — | $1.7M |
| Other Current Liab | $2.7M | — | $1.6M |
| Long-Term Liabilities | $0 | — | $2.9M |
| Total Liabilities | $2.8M | $3.0M | $4.5M |
| Shareholders' Equity | $-2.6M | $-2.6M | $-4.1M |
| Paid-In Capital | $1.9M | $3.2M | $5.9M |
| Retained Earnings | $-4.5M | $-6.3M | $-10.4M |
| Total L&E | $205.0K | $474.0K | $385.0K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-1.3M | $-1.8M | $-4.0M |
| Non-Cash Adjustments | $681.0K | $1.0M | $3.3M |
| Working Capital Changes | $28.0K | $210.0K | $-20.0K |
| Cash from Operations | $-595.0K | $-597.0K | $-785.0K |
| Cash from Investing | $0 | $-93.0K | $-80.0K |
| Cash from Financing | $442.0K | $865.0K | $719.0K |
| FX Effect | $7.0K | $-13.0K | $3.0K |
| Net Change in Cash | $-146.0K | $162.0K | $-143.0K |
| Beginning Cash | $206.0K | $60.0K | $222.0K |
| Ending Cash | $60.0K | $222.0K | $79.0K |
Frequently Asked Questions
How does APPYEA, INC make money?
The primary business segment appears to be speculative or in early development given the lack of meaningful revenue streams, with financial activity driven by share issuances totaling $612k and significant non-operating losses of $2.2M rather than core product sales.
What are the main risks for APYP?
The company faces extreme liquidity risk with operating cash flow of -$785k and negative shareholders' equity. There is a high risk of delisting or insolvency given total liabilities of $4.5M against current assets of only $131k. The business model remains unproven with five years of consecutive losses deepening from -$1.3M to -$4.0M.
What is APYP's competitive advantage?
None identified based on current financials; the company lacks traditional moats due to negative equity of -$4.1M, minimal revenue, and a net fixed asset base that is negligible compared to liabilities.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.